CJC-1295 + IPAMORELIN Blend - 10 mg

CJC-1295 (No DAC) + Ipamorelin is a dual-peptide research blend formulated for laboratory investigation of growth hormone-related signaling pathways.

CJC-1295 (No DAC), also commonly referred to as Modified GRF (1-29), is a synthetic analogue of growth hormone-releasing hormone (GHRH). Ipamorelin is a synthetic pentapeptide that acts as an agonist of the growth hormone secretagogue receptor (GHS-R1a). Combining these compounds provides researchers with a convenient formulation for studying two distinct signaling mechanisms associated with the growth hormone axis.

Research Areas

CJC-1295 (No DAC) and Ipamorelin are commonly investigated in research involving:

• GHRH receptor signaling • GHS-R1a / ghrelin receptor signaling • Growth hormone secretagogue pathways • Pulsatile growth hormone release • GH/IGF-1 axis signaling • Pituitary and neuroendocrine signaling • Comparative peptide and secretagogue research • Multi-pathway endocrine signaling

Product Specifications

Product: CJC-1295 (No DAC) + Ipamorelin Total Content: 10 mg per vial Form: Lyophilized powder Classification: GHRH analogue + growth hormone secretagogue Testing: Batch-specific analytical testing Certificate of Analysis: Available for verified lots

Why No DAC?

This formulation specifically contains CJC-1295 without Drug Affinity Complex (DAC). The No-DAC form is relevant to laboratory models investigating shorter-duration GHRH-receptor signaling and pulsatile pathway activity, distinguishing it from longer-acting CJC-1295 variants containing DAC.

Quality & Verification

BioNova Peptides prioritizes transparent, batch-specific analytical documentation. Researchers should reference the Certificate of Analysis associated with the applicable lot for available identity, purity, and analytical testing information.

Storage

Store lyophilized material under appropriate controlled laboratory conditions, protected from excessive heat, moisture, and light. Refer to applicable laboratory protocols and batch documentation for handling requirements.

Research Use Only

This product is supplied strictly for laboratory research purposes only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, dietary, or clinical applications. No dosing or administration guidance is provided.

Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂ (CJC-1295) | C₃₈H₄₉N₉O₅ (Ipamorelin) Description: This analytical blend combines a Growth Hormone Releasing Hormone (GHRH) analog with a selective Growth Hormone Secretagogue (GHS). The combination is designed to examine the dual-pathway stimulation of the pituitary gland in vitro. All products sold by BioNova Peptides are intended for laboratory research use only. Not for human consumption, medical, clinical, or veterinary use. These products are not drugs, food additives, or dietary supplements. BioNova Peptides does not promote or support the use of any product for human use.